Su Kaiyan相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

AI-guided design and optimization of a novel KIM-1-targeted peptide for bFGF delivery in acute kidney injury repair.

AI引导的新型KIM-1靶向肽的设计和优化，用于急性肾损伤修复中的bFGF递送。

期刊:Regenerative Biomaterials

影响因子:8.1

doi:10.1093/rb/rbag050

Su Kaiyan, Liu Zhuo, Fu Pengrui, Zhou Runxue, Xia Hao, Nie Weihong, Sun Shuwei, Shi Chunying, Chen Wei

发表日期：2026

文献求助收藏

Bilirubin Targeting WNK1 to Alleviate NLRP3-Mediated Neuroinflammation.

胆红素靶向WNK1以缓解NLRP3介导的神经炎症

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202407349

Mao Linfei, Lu Jiayu, Yang Quanjun, Liu Zhenqi, Wu Cuiping, Ke Bingbing, Su Kaiyan, Yuan Haolin, Cui Yaqi, Wang Yao, Salvi Richard, Yang Guang, Yin Shankai, Liu Feng, Li Chunyan

发表日期：2025

文献求助收藏

Comparison of the efficacy and safety of TACE-HAIC-MTTs-ICIs and TACE-MTTs-ICIs in the hepatocellular carcinoma: a prognostic analysis based on the dynamic changes of serum AFP

比较TACE-HAIC-MTTs-ICIs和TACE-MTTs-ICIs治疗肝细胞癌的疗效和安全性：基于血清AFP动态变化的预后分析

期刊:International Journal of Surgery

影响因子:10.1

doi:10.1097/JS9.0000000000002818

Li, Wenli; Lu, Mingjian; Yuan, Guosheng; Shi, Feng; Zang, Mengya; Hu, Xiaoyun; Li, Qi; Zhu, Peilin; Chen, Yongru; Zhao, Jingyi; Su, Kaiyan; Peng, Yunheng; Chen, Jinzhang

细胞生物学

发表日期：2025

文献求助收藏

Camrelizumab Combined with Lenvatinib and RALOX-Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma (Cal Era): A Prospective, Single-Arm, Phase II Trial

卡瑞利珠单抗联合乐伐替尼和RALOX-肝动脉灌注化疗治疗不可切除的肝细胞癌（Cal Era）：一项前瞻性、单臂、II期试验

期刊:Liver Cancer

影响因子:9.1

doi:10.1159/000546575

Zang, Mengya; Li, Qi; Hu, Xiaoyun; Pang, Huajin; Li, Rong; Li, Wenli; Chen, Yongru; Zhu, Peilin; Su, Kaiyan; Yuan, Guosheng; Li, Yuan; Li, Yuanfeng; Chen, Jinzhang

细胞生物学

发表日期：2025

文献求助收藏

Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma

低水平病毒血症会降低免疫检查点抑制剂在不可切除肝细胞癌中的疗效

期刊:Liver International

影响因子:5.2

doi:10.1111/liv.70066

Li, Rong; Li, Wenli; Yang, Qing; Guan, Yujuan; Chen, Yongru; Zhu, Peilin; Su, Kaiyan; Li, Qi; Hu, Xiaoyun; Zang, Mengya; Zhao, Miaoxian; Zhong, Manhua; Yan, Jingquan; Yang, Keli; Zhu, Wei; Lin, Zhanzhou; Yuan, Guosheng; Chen, Jinzhang

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis

肝脏全基因组增强子-基因调控图谱揭示了NAFLD发病机制中新的调控机制

期刊:BMC Genomics

影响因子:3.7

doi:10.1186/s12864-025-11668-w

Li, Ruofan; Su, Kaiyan; Wu, Tianzhun; Xu, Li; Song, Wenyu; Sun, Dandan; Zeng, Tao; Chen, Jinzhang; Xin, Haibei; Li, Yuanfeng; Zang, Mengya; Hu, Minggen

发表日期：2025

文献求助收藏

Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study

卡多尼利单抗（PD-1/CTLA-4）联合乐伐替尼治疗不可切除肝细胞癌（uHCC）：一项回顾性真实世界研究

影响因子:3.6

doi:10.1016/j.heliyon.2024.e37616

Yuan, Guosheng; Chen, Yongru; Zhu, Peilin; Deng, Qiong; Su, Kaiyan; Liu, Jie; Wang, Yan; Li, Rong; Li, Wenli; Zang, Mengya; Hu, Xiaoyun; Wang, Jun-Jie; Li, Qi; Du, Yangfeng; Chen, Jinzhang

细胞生物学

发表日期：2024

文献求助收藏